Intra-VTA adenosine A1 receptor activation blocks morphine stimulation of motor behavior and cortical and limbic Fos immunoreactivity

European Journal of Pharmacology

Volumn 602, Issue 2-3, 2009, Pages 268-276

  Kaplan, Gary B ^a,b,c   Leite Morris, Kimberly A ^a,b,c   Klufas, Michael A ^c   Fan, WenYing ^a,b  

^a VA BOSTON HEALTHCARE SYSTEM   (United States)

^b Division of Psychiatry   (United States)

^c PROVIDENCE VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Adenosine A1 receptor; c Fos; Morphine; Opioid; Ventral tegmental area

Indexed keywords

6 N CYCLOPENTYLADENOSINE; ADENOSINE A1 RECEPTOR AGONIST; ADENOSINE A1 RECEPTOR ANTAGONIST; MORPHINE; OPIATE; PROTEIN C FOS; PROTEIN FOS; PURINERGIC RECEPTOR AFFECTING AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CINGULATE GYRUS; CONTROLLED STUDY; DOPAMINERGIC TRANSMISSION; DOSE RESPONSE; DRUG ABUSE; DRUG RECEPTOR BINDING; GABAERGIC TRANSMISSION; IMMEDIATE EARLY GENE; IMMUNOREACTIVITY; LIMBIC CORTEX; LOCOMOTION; MALE; MOTOR ACTIVITY; MOTOR CORTEX; MOUSE; NONHUMAN; NUCLEUS ACCUMBENS; ONCOGENE C FOS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SINGLE DRUG DOSE; VENTRAL TEGMENTUM;

ADENOSINE; ANIMALS; BIOLOGICAL MARKERS; CEREBRAL CORTEX; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION; LIMBIC SYSTEM; MALE; MICE; MICE, INBRED C57BL; MORPHINE; MOTOR ACTIVITY; NEURONS; NUCLEUS ACCUMBENS; PROTO-ONCOGENE PROTEINS C-FOS; RECEPTOR, ADENOSINE A1; THEOPHYLLINE; VENTRAL TEGMENTAL AREA;

EID: 58149145445     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2008.10.052     Document Type: Article

References (45)

1. Ahlijanian M.K., and Takemori A.E. Changes in adenosine receptor sensitivity in morphine-tolerant and -dependent mice. J. Pharmacol. Exp. Ther. 236 (1986) 615-620
2. Barrot M., Marinelli M., Abrous D.N., Rouge-Pont F., Le Moal M., and Piazza P.V. Functional heterogeneity in dopamine release and in the expression of Fos-like proteins within the rat striatal complex. Eur. J. Neurosci. 11 (1999) 1155-1166
3. Bonci A., and Williams J.T. A common mechanism mediates long-term changes in synaptic transmission after chronic cocaine and morphine. Neuron 16 (1996) 631-639
4. Bontempi B., and Sharp F.R. Systemic morphine induced Fos protein in the rat striatum and nucleus accumbens is regulated by mu opioid receptors in the substantia nigra and ventral tegmental area. J. Neurosci. 17 (1997) 8596-8612
5. Carr D.B., and Sesack S.R. Projections from the rat prefrontal cortex to the ventral tegmental area: target specificity in the synaptic associations with mesoaccumbens and mesocortical neurons. J. Neurosci. 20 (2000) 3864-3873
6. Di Chiara G. The role of dopamine in drug abuse viewed from the perspective of its role in motivation. Drug Alcohol Depend. 38 (1995) 95-137
7. Di Chiara G., and Imperato A. Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats. J. Pharmacol. Exp. Ther. 244 (1988) 1067-1080
8. Dionyssopoulos T., Hope W., and Coupar I.M. Effect of adenosine analogues on the expression of opiate withdrawal in rats. Pharmacol. Biochem. Behav. 42 (1992) 201-206
9. Fiorillo C.D., and Williams J.T. Selective inhibition by adenosine of mGluR IPSPs in dopamine neurons after cocaine treatment. J. Neurophysiol. 83 (2000) 1307-1314
10. Franklin K.B.J., and Paxinos G. The Mouse Brain in Stereotaxic Coordinates (1997), Academic Press, Inc., San Diego, CA
11. Fuxe K., Ferre S., Zoli M., and Agnati L.F. Integrated events in central dopamine transmission as analyzed at multiple levels: evidence for intramembrane adenosine A2A/dopamine D2 and adenosine A1/dopamine D1 receptor interactions in the basal ganglia. Brain Res. Brain Res. Rev. 26 (1998) 258-273
12. Johnson S.W., and North R.A. Opioids excite dopamine neurons by hyperpolarization of local interneurons. J. Neurosci. 12 (1992) 483-488
13. Kalivas P.W. Neurotransmitter regulation of dopamine neurons in the ventral tegmental area. Brain Res. Brain Res. Rev. 18 (1993) 75-113
14. Kaplan G.B., and Sears M.T. Adenosine receptor agonists attenuate and adenosine receptor antagonists exacerbate opiate withdrawal signs. Psychopharmacology 123 (1996) 64-70
15. Kaplan G.B., and Leite-Morris K.A. Up-regulation of adenosine transporter-binding sites in striatum and hypothalamus of opiate tolerant mice. Brain Res. 763 (1997) 215-220
16. Kaplan G.B., and Coyle T.S. Adenosine kinase inhibitors attenuate opiate withdrawal via adenosine receptor activation. Eur. J. Pharmacol. 362 (1998) 1-8
17. Kaplan G.B., Leite-Morris K.A., and Sears M.T. Alterations of adenosine A1 receptors in morphine dependence. Brain Res. 657 (1994) 347-350
18. Karcz-Kubicha M., Antoniou K., Terasmaa A., Quarta D., Solinas M., Justinova Z., Pezzola A., Reggio R., Mueller C.E., Fuxe K., Goldberg S.R., Popoli P., and Ferre S. Involvement of adenosine A1 and A2A receptors in the motor effects of caffeine after its acute and chronic administration. Neuropsychopharmacology 28 (2003) 1281-1291
19. Kauer J.A. Learning mechanisms in addiction: synaptic plasticity in the ventral tegmental area as a result of exposure to drugs of abuse. Annu. Rev. Physiol. 66 (2004) 447-475
20. Klitenick M.A., DeWitte P., and Kalivas P.W. Regulation of somatodendritic dopamine release in the ventral tegmental area by opioids and GABA: an in vivo microdialysis study. J. Neurosci. 12 (1992) 2623-2632
21. Kuzmin A., Johansson B., Zvartau E.E., and Fredholm B.B. Caffeine, acting on adenosine A1 receptors, prevents the extinction of cocaine-seeking behavior in mice. J. Pharmacol. Exp. Ther. 290 (1999) 535-542
22. Kuzmin A., Johansson B., Gimenez L., Ogren S.O., and Fredholm B.B. Combination of adenosine A1 and A2A receptor blocking agents induces caffeine-like locomotor stimulation in mice. Eur. Neuropsychopharmacol. 16 (2006) 129-136
23. Laviolette S.R., Gallegos R.A., Henriksen S.J., and van der Kooy D. Opiate state controls bi-directional reward signaling via GABAA receptors in the ventral tegmental area. Nat. Neurosci. 7 (2004) 160-169
24. Leite-Morris K.A., Fukudome E.Y., Shoeb M., and Kaplan G.B. GABA(B) receptor activation in the ventral tegmental area inhibits the acquisition and expression of opiate induced motor sensitization. J. Pharmacol. Exp. Ther. 308 (2004) 667-678
25. Liu J., Nickolenko J., and Sharp F.R. Morphine induces c-fos and junB in striatum and nucleus accumbens via D1 and N-methyl-d-aspartate receptors. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 8537-8541
26. Murai T., Koshikawa N., Kanayama T., Takada K., Tomiyama K., and Kobayashi M. Opposite effects of midazolam and beta-carboline-3-carboxylate ethyl ester on the release of dopamine from rat nucleus accumbens measured by in vivo microdialysis. Eur. J. Pharmacol. 261 (1994) 65-71
27. Murphy N.P., Lam H.A., and Maidment N.T. A comparison of morphine induced locomotor activity and mesolimbic dopamine release in C57BL6, 129Sv and DBA2 mice. J. Neurochem. 79 (2001) 626-635
28. Okada M., Mizuno K., and Kaneko S. Adenosine A1 and A2 receptors modulate extracellular dopamine levels in rat striatum. Neurosci. Lett. 212 (1996) 53-56
29. Olson V.G., Zabetian C.P., Bolanos C.A., Edwards S., Barrot M., Eisch A.J., Hughes T., Self D.W., Neve R.L., and Nestler E.J. Regulation of drug reward by cAMP response element-binding protein: evidence for two functionally distinct subregions of the ventral tegmental area. J. Neurosci. 25 (2005) 5553-5562
30. Phillis J.W., Barraco R.A., DeLong R.E., and Washington D.O. Behavioral characteristics of centrally administered adenosine analogs. Pharmacol. Biochem. Behav. 24 (1986) 263-270
31. Pontieri F.E., Tanda G., and Di Chiara G. Intravenous cocaine, morphine, and amphetamine preferentially increase extracellular dopamine in the "shell" as compared with the "core" of the rat nucleus accumbens. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 12304-12308
32. Quarta D., Borycz J., Solinas M., Patkar K., Hockemeyer J., Ciruela F., Lluis C., Franco R., Woods A.S., Goldberg S.R., and Ferré S. Adenosine receptor-mediated modulation of dopamine release in the nucleus accumbens depends on glutamate neurotransmission and N-methyl-d-aspartate receptor stimulation. J. Neurochem. 91 (2004) 873-880
33. Rivkees S.A., Price S.L., and Zhou F.C. Immunohistochemical detection of A1 adenosine receptors in rat brain with emphasis on localization in the hippocampal formation, cerebral cortex, cerebellum, and basal ganglia. Brain Res. 677 (1995) 193-203
34. Salem A., and Hope W. Effect of adenosine receptor agonists and antagonists on the expression of opiate withdrawal in rats. Pharmacol. Biochem. Behav. 57 (1997) 671-679
35. Schwienbacher I., Fendt M., Hauber W., and Koch M. Dopamine D1 receptors and adenosine A1 receptors in the rat nucleus accumbens regulate motor activity but not prepulse inhibition. Eur. J. Pharmacol. 444 (2002) 161-169
36. Shimazoe T., Yoshimatsu A., Kawashimo A., and Watanabe S. Roles of adenosine A1 and A2 receptors in the expression and development of methamphetamine-induced sensitization. Eur. J. Pharmacol. 388 (2000) 249-254
37. Solinas M., Ferre S., You Z.B., Karcz-Kubicha M., Popoli P., and Goldberg S.R. Caffeine induces dopamine and glutamate release in the shell of the nucleus accumbens. J. Neurosci. 22 (2002) 6321-6324
38. Svenningsson P., Hall H., Sedvall G., and Fredholm B.B. Distribution of adenosine receptors in the postmortem human brain: an extended autoradiographic study. Synapse 27 (1997) 322-335
39. Svingos A.L., Garzón M., Colago E.E., and Pickel V.M. Mu-opioid receptors in the ventral tegmental area are targeted to presynaptically and directly modulate mesocortical projection neurons. Synapse 41 (2001) 221-229
40. Van Bockstaele E.J., and Pickel V.M. GABA-containing neurons in. the ventral tegmental area project to nucleus accumbens in rat brain. Brain Res. 682 (1995) 215-221
41. Wang T., and French E.D. NMDA, kainate, and AMPA depolarize nondopamine neurons in the rat ventral tegmentum. Brain Res. Bull. 36 (1995) 39-43
42. Wu Y.N., Mercuri N.B., and Johnson S.W. Presynaptic inhibition of gamma-aminobutyric acidB-mediated synaptic current by adenosine recorded in vitro in midbrain dopamine neurons. J. Pharmacol. Exp. Ther. 273 (1995) 576-581
43. Wu Y.N., Shen K.Z., and Johnson S.W. Presynaptic inhibition preferentially reduces the NMDA receptor-mediated component of transmission in rat midbrain dopamine neurons. Br. J. Pharmacol. 127 (1999) 1422-1430
44. Xi Z.X., Wu G., Stein E.A., and Li S.J. Opiate tolerance by heroin self-administration: an fMRI study in rat. Magn. Reson. Med. 52 (2004) 108-114
45. Zocchi A., Girlanda E., Varnier G., Sartori I., Zanetti L., Wildish G.A., Lennon M., Mugnaini M., and Heidbreder C.A. Dopamine responsiveness to drugs of abuse: a shell-core investigation in the nucleus accumbens of the mouse. Synapse 50 (2003) 293-302